https://www.pacificbridgemedical.com/news-brief/chinas-two-invoice-policy-will-significantly-change-pharmaceutical-industry/ 2024-09-17T16:44:03+00:00 https://www.pacificbridgemedical.com/news-brief/india-proposes-cut-prices-cardiac-stents/ 2024-09-17T16:43:45+00:00 https://www.pacificbridgemedical.com/news-brief/cctv-investigation-reveals-widespread-huge-kickback-culture-china/ 2024-09-17T16:43:33+00:00 https://www.pacificbridgemedical.com/news-brief/india-finally-establishes-separate-regulations-medical-devices-pharmaceuticals/ 2024-09-17T16:40:32+00:00 https://www.pacificbridgemedical.com/news-brief/india-fixes-stent-prices-looks-fix-prices-14-medical-devices/ 2024-09-17T16:39:50+00:00 https://www.pacificbridgemedical.com/news-brief/japan-targets-higher-percentage-generic-drug-use/ 2024-09-17T05:51:05+00:00 https://www.pacificbridgemedical.com/news-brief/china-use-clinical-pathways-drgs-curb-healthcare-spending/ 2024-09-17T05:47:20+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-cancer-deaths-attributable-lifestyle-factors/ 2024-09-17T05:40:07+00:00 https://www.pacificbridgemedical.com/news-brief/new-mandatory-medical-device-adverse-event-reporting-malaysia/ 2024-09-17T05:39:48+00:00 https://www.pacificbridgemedical.com/news-brief/artificial-intelligence-china/ 2024-09-17T05:39:19+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-updates-exempt-device-requirements/ 2024-09-17T05:34:49+00:00 https://www.pacificbridgemedical.com/news-brief/convenience-stores-selling-otc-drugs-korea/ 2024-09-17T05:23:56+00:00 https://www.pacificbridgemedical.com/news-brief/chinese-biotech-firms-raising-billions-boost-drug-innovation/ 2024-09-17T05:20:43+00:00 https://www.pacificbridgemedical.com/news-brief/china-moves-toward-60-day-clinical-trial-reviews-drugs/ 2024-09-17T05:14:15+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-cfda-issues-guidelines-medical-device-clinical-trials/ 2024-09-17T05:13:26+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-extends-registration-deadline-class-b-c-d-devices/ 2024-09-17T05:12:34+00:00 https://www.pacificbridgemedical.com/news-brief/india-proposes-local-sourcing-requirements-for-medical-devices/ 2024-09-17T05:10:33+00:00 https://www.pacificbridgemedical.com/news-brief/new-labeling-guidelines-devices-malaysia/ 2024-09-17T05:10:11+00:00 https://www.pacificbridgemedical.com/news-brief/china-expanding-insurance-coverage-for-catastrophic-illness/ 2024-09-17T05:08:05+00:00 https://www.pacificbridgemedical.com/news-brief/japan-pharmaceutical-market-set-for-growth/ 2024-09-17T05:07:44+00:00 https://www.pacificbridgemedical.com/news-brief/japan-increases-medical-device-registration-fees/ 2024-09-17T05:06:52+00:00 https://www.pacificbridgemedical.com/news-brief/china-speeds-review-procedures-for-approval-of-orphan-drugs/ 2024-09-17T05:02:50+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-require-warning-display-on-high-risk-drugs/ 2024-09-17T05:01:53+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-to-cover-public-health-related-clinical-trials/ 2024-09-17T05:01:21+00:00 https://www.pacificbridgemedical.com/news-brief/china-rare-disease-list-likely-to-spur-development-of-orphan-drugs/ 2024-09-17T05:00:50+00:00 https://www.pacificbridgemedical.com/news-brief/india-expands-regulation-of-medical-devices/ 2024-09-17T04:59:23+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-hones-voluntary-medical-device-registration-system/ 2024-09-17T04:58:51+00:00 https://www.pacificbridgemedical.com/news-brief/china-eases-medical-device-renewal-and-clinical-trial-requirements/ 2024-09-17T04:31:07+00:00 https://www.pacificbridgemedical.com/news-brief/china-eases-approvals-of-drugs-to-treat-life-threatening-diseases/ 2024-09-17T04:29:22+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-extends-medical-device-registration-deadline-another-year/ 2024-09-17T04:29:08+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-to-allow-speedier-approval-of-some-medical-devices/ 2024-09-17T04:26:10+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-to-implement-moderate-fee-increases-on-device-registrations/ 2024-09-17T04:20:14+00:00 https://www.pacificbridgemedical.com/news-brief/emergency-drugs-in-china-scarce-shortfall-severe-doctors-say/ 2024-09-16T21:02:12+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-a-magnet-for-big-pharma/ 2024-09-16T21:01:38+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-to-raise-fees-on-licensing-registration-of-medical-devices/ 2024-09-16T17:48:12+00:00 https://www.pacificbridgemedical.com/news-brief/medical-device-re-registration-starting-in-malaysia/ 2024-09-16T03:03:43+00:00 https://www.pacificbridgemedical.com/news-brief/china-puts-medical-device-identification-system-requirements-in-motion/ 2024-09-16T03:01:29+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-lays-groundwork-for-insurance-reimbursement-of-digital-therapeutics-technologies/ 2024-09-15T19:30:59+00:00 https://www.pacificbridgemedical.com/news-brief/formal-acceptance-of-a-mdsap-report-begins-in-japan-early-next-year/ 2024-09-15T19:29:55+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-new-order-739-includes-new-device-regulations/ 2024-09-15T18:32:31+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-plans-to-authorize-real-world-studies-of-orphan-drugs/ 2024-09-15T18:31:59+00:00 https://www.pacificbridgemedical.com/news-brief/korean-institute-calls-for-regulation-of-wearable-health-care-apps/ 2024-09-15T18:29:06+00:00 https://www.pacificbridgemedical.com/news-brief/software-reimbursement-to-be-looked-at-more-seriously-in-japan/ 2024-09-15T18:26:02+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-tightens-requirements-on-labeling-of-products/ 2024-09-15T18:24:41+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-concludes-classification-guidance-comment-period/ 2024-09-15T18:16:17+00:00 https://www.pacificbridgemedical.com/news-brief/japan-further-expediting-medical-products-due-to-emergencies/ 2024-09-15T17:57:35+00:00 https://www.pacificbridgemedical.com/news-brief/ustr-releases-report-including-comments-on-chinas-device-market/ 2024-09-15T17:56:57+00:00 https://www.pacificbridgemedical.com/news-brief/new-labeling-requirements-in-vietnam/ 2024-09-15T17:56:27+00:00 https://www.pacificbridgemedical.com/news-brief/japan-reduces-many-drug-prices-but-some-will-go-up-slightly-too/ 2024-09-15T17:56:00+00:00 https://www.pacificbridgemedical.com/news-brief/japan-continues-to-reduce-medical-device-reimbursements/ 2024-09-15T17:55:03+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-to-launch-a-new-good-pharmacovigilance-inspection-program/ 2024-09-15T17:54:26+00:00 https://www.pacificbridgemedical.com/news-brief/good-clinical-practice-for-medical-devices-in-china-update/ 2024-09-15T17:53:32+00:00 https://www.pacificbridgemedical.com/news-brief/new-cdx-requirements-in-japan/ 2024-09-15T17:52:03+00:00 https://www.pacificbridgemedical.com/news-brief/japans-pmda-to-do-more-surprise-gmp-inspections-for-high-risk-sites/ 2024-09-15T17:47:29+00:00 https://www.pacificbridgemedical.com/news-brief/hainan-island-new-device-release-increases-gateway-to-china/ 2024-09-15T17:43:31+00:00 https://www.pacificbridgemedical.com/news-brief/japan-drug-pricing-could-lead-to-return-of-drug-lag/ 2024-09-15T17:43:08+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-drug-market-to-continue-to-grow-despite-price-cuts/ 2024-09-15T17:22:21+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-issues-new-rules-for-medical-device-classification/ 2024-09-15T17:21:44+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-to-accept-online-submissions/ 2024-09-15T17:13:17+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-puts-forward-significant-drug-changes/ 2024-09-15T17:12:14+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-do-more-drug-inspections/ 2024-09-15T17:11:44+00:00 https://www.pacificbridgemedical.com/news-brief/indian-device-licenses-approved-during-the-pandemic-could-be-at-risk/ 2024-09-15T17:11:11+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-may-accelerate-local-clinical-trial-requirements-for-drugs-in-high-demand/ 2024-09-15T17:08:56+00:00 https://www.pacificbridgemedical.com/news-brief/revised-chinese-regulations-should-help-aid-laboratory-developed-tests/ 2024-09-15T17:08:35+00:00 https://www.pacificbridgemedical.com/news-brief/update-chinas-healthcare-privacy-laws/ 2024-09-15T17:04:14+00:00 https://www.pacificbridgemedical.com/news-brief/korean-governments-drug-prices-not-conducive-for-new-drugs/ 2024-09-15T17:03:42+00:00 https://www.pacificbridgemedical.com/news-brief/japan-to-revise-drug-prices-in-2023/ 2024-09-15T17:02:33+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-drug-prices-will-continue-to-fall/ 2024-09-15T17:02:00+00:00 https://www.pacificbridgemedical.com/news-brief/quicker-access-to-chinas-healthcare-markets/ 2024-09-15T16:58:22+00:00 https://www.pacificbridgemedical.com/news-brief/japan-mhlws-seeking-more-funds-to-incentivize-orphan-drug-development/ 2024-09-15T16:57:50+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-new-strict-regulation-for-online-sales-of-drugs/ 2024-09-15T16:42:18+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-updates-establishment-licensing-for-medical-devices/ 2024-09-15T16:41:41+00:00 https://www.pacificbridgemedical.com/news-brief/china-nmpa-issued-new-regulation-on-drug-recalls/ 2024-09-15T16:34:03+00:00 https://www.pacificbridgemedical.com/news-brief/korea-enacts-new-device-renewal-requirements/ 2024-09-15T16:33:26+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-draft-regulation-on-api-registration-renewal/ 2024-09-15T16:32:33+00:00 https://www.pacificbridgemedical.com/news-brief/japanese-drug-survey-may-lead-to-a-relaxation-of-price-cuts/ 2024-09-15T16:31:57+00:00 https://www.pacificbridgemedical.com/news-brief/china-nmpa-updated-electric-medical-equipment-standards/ 2024-09-15T16:13:45+00:00 https://www.pacificbridgemedical.com/news-brief/japan-increases-the-number-of-applications-to-be-submitted-online/ 2024-09-15T16:12:34+00:00 https://www.pacificbridgemedical.com/news-brief/increasing-demand-for-devices-in-china/ 2024-09-15T05:43:01+00:00 https://www.pacificbridgemedical.com/news-brief/decentralized-clinical-trials-dct-growing-in-china/ 2024-09-15T05:42:38+00:00 https://www.pacificbridgemedical.com/news-brief/korea-to-initiate-on-site-device-kgmp-audits-on-january-1-2023/ 2024-09-15T05:40:10+00:00 https://www.pacificbridgemedical.com/news-brief/china-cracks-down-on-ip-issues-for-drug-procurement/ 2024-09-15T05:36:52+00:00 https://www.pacificbridgemedical.com/news-brief/japan-takes-additional-steps-to-expedite-samd-and-ai-products/ 2024-09-15T05:36:22+00:00 https://www.pacificbridgemedical.com/news-brief/china-updates-device-master-files/ 2024-09-15T05:23:23+00:00 https://www.pacificbridgemedical.com/news-brief/conditional-drug-approval-in-china-new-cde-comments/ 2024-09-15T05:19:03+00:00 https://www.pacificbridgemedical.com/news-brief/india-plans-to-increase-its-medical-device-production/ 2024-09-15T05:18:03+00:00 https://www.pacificbridgemedical.com/news-brief/india-delays-some-medical-device-license-requirements/ 2024-09-15T05:17:32+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-announces-plans-for-ich-ectd-for-drug-approvals/ 2024-09-15T05:17:07+00:00 https://www.pacificbridgemedical.com/news-brief/china-personal-data-transfer-for-drugs-becoming-more-strict/ 2024-09-15T05:16:05+00:00 https://www.pacificbridgemedical.com/news-brief/japan-outlines-new-medical-device-cybersecurity-regulation/ 2024-09-15T05:15:43+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-8th-national-volume-based-procurement-vbp/ 2024-09-15T05:15:23+00:00 https://www.pacificbridgemedical.com/news-brief/indian-clinical-trials-growing-again/ 2024-09-15T05:12:08+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-is-now-issuing-electronic-medical-device-certificates/ 2024-09-15T05:11:43+00:00 https://www.pacificbridgemedical.com/news-brief/china-initiates-new-pilot-programs-for-lab-developed-tests-ldts/ 2024-09-15T05:09:41+00:00 https://www.pacificbridgemedical.com/news-brief/japan-now-considering-a-two-stage-approval-process-for-samd-products/ 2024-09-15T05:08:32+00:00 https://www.pacificbridgemedical.com/news-brief/china-releases-new-medical-device-guidelines/ 2024-09-15T05:07:52+00:00 https://www.pacificbridgemedical.com/news-brief/90-of-japan-drug-prices-reduced-in-april/ 2024-09-15T05:04:36+00:00 https://www.pacificbridgemedical.com/news-brief/china-cancer-drug-market-growing-quickly/ 2024-09-15T05:04:04+00:00 https://www.pacificbridgemedical.com/news-brief/cdx-development-slow-in-china/ 2024-09-15T05:02:26+00:00 https://www.pacificbridgemedical.com/news-brief/japans-government-sets-up-study-group-for-drug-lag-problem/ 2024-09-15T05:01:33+00:00 https://www.pacificbridgemedical.com/news-brief/will-china-relax-tough-drug-prices/ 2024-09-15T05:00:55+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-budget-will-grow-in-2024-to-expedite-drug-approvals/ 2024-09-15T04:52:44+00:00 https://www.pacificbridgemedical.com/news-brief/china-embraces-decentralized-clinical-trials-dct/ 2024-09-15T04:51:40+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-now-offers-new-medical-device-consultation-services/ 2024-09-15T04:51:09+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-adjusts-medical-device-classification-catalog/ 2024-09-15T04:50:44+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-new-regulations-for-human-genetic-resources-hgr/ 2024-09-15T04:50:12+00:00 https://www.pacificbridgemedical.com/news-brief/koreas-locally-made-device-market-is-growing-quickly/ 2024-09-15T04:48:16+00:00 https://www.pacificbridgemedical.com/news-brief/china-strives-to-improve-drug-safety/ 2024-09-15T04:45:54+00:00 https://www.pacificbridgemedical.com/news-brief/asias-cdx-market-poised-for-growth/ 2024-09-15T04:33:41+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-health-sector-opening-up/ 2024-09-15T04:32:58+00:00 https://www.pacificbridgemedical.com/news-brief/indian-government-cracking-down-on-its-drug-manufacturers/ 2024-09-15T04:30:31+00:00 https://www.pacificbridgemedical.com/news-brief/china-squeezes-kickbacks-in-its-pharma-sector/ 2024-09-15T04:27:39+00:00 https://www.pacificbridgemedical.com/news-brief/korean-healthcare-ai-usage-is-expected-to-explode/ 2024-09-15T04:26:22+00:00 https://www.pacificbridgemedical.com/news-brief/china-introduces-9th-round-of-volume-based-procurement/ 2024-09-15T04:23:40+00:00 https://www.pacificbridgemedical.com/news-brief/robotic-surgical-device-sales-to-grow-the-fastest-in-asia/ 2024-09-15T04:21:34+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-continues-to-improve-its-medical-device-registration-system/ 2024-09-15T04:21:08+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-updated-faqs-for-human-genetic-resource-hgr/ 2024-09-15T04:19:35+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-becoming-more-popular-for-drug-clinical-research/ 2024-09-15T04:03:08+00:00 https://www.pacificbridgemedical.com/news-brief/india-dcgi-extends-device-registration/ 2024-09-15T04:02:41+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-releases-new-report-on-drug-clinical-trials/ 2024-09-15T04:02:10+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-second-list-of-rare-diseases/ 2024-09-15T03:48:41+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-joins-ich-as-an-observer/ 2024-09-15T03:42:30+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-looks-to-reduce-drug-prices/ 2024-09-15T03:42:05+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-new-device-guidance-on-real-world-evidence/ 2024-09-14T21:24:56+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-continues-to-push-forth-new-increased-drug-pricing-plans/ 2024-09-14T21:24:16+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-introduces-new-labeling-requirements-for-drugs/ 2024-09-14T21:16:45+00:00 https://www.pacificbridgemedical.com/news-brief/other-asian-regulatory-updates/ 2024-09-14T21:16:28+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-announces-new-drug-registration-process-1-mechanism/ 2024-09-14T21:15:52+00:00 https://www.pacificbridgemedical.com/news-brief/laos-further-clarifies-medical-device-registration/ 2024-09-14T21:15:25+00:00 https://www.pacificbridgemedical.com/news-brief/china-adds-new-drugs-to-its-national-reimbursement-drug-list-nrdl/ 2024-09-14T21:14:02+00:00 https://www.pacificbridgemedical.com/news-brief/japan-continues-its-efforts-to-boost-its-drug-market/ 2024-09-14T21:13:34+00:00 https://www.pacificbridgemedical.com/news-brief/taiwans-tfda-announces-new-device-regulations/ 2024-09-14T21:12:05+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asian-news-brief-updates/ 2024-09-14T21:05:04+00:00 https://www.pacificbridgemedical.com/news-brief/japans-government-continues-new-policies-to-expedite-registration/ 2024-09-14T21:04:31+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-publishes-a-new-device-technical-document/ 2024-09-14T21:03:18+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asian-medical-device-regulatory-updates/ 2024-09-14T18:59:48+00:00 https://www.pacificbridgemedical.com/news-brief/western-drug-companies-continue-their-investments-in-chinas-biotech/ 2024-09-14T18:57:35+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-looks-to-further-define-its-patent-law/ 2024-09-14T18:57:06+00:00 https://www.pacificbridgemedical.com/news-brief/japan-wants-to-streamline-its-drug-clinical-trial-processes/ 2024-09-14T18:56:37+00:00 https://www.pacificbridgemedical.com/news-brief/data-sharing-between-us-and-china-heats-up/ 2024-09-14T18:55:58+00:00 https://www.pacificbridgemedical.com/news-brief/corruption-crackdown-accelerates-in-chinas-healthcare-system/ 2024-09-14T18:53:14+00:00 https://www.pacificbridgemedical.com/news-brief/indian-drug-prices-do-not-increase-in-2024/ 2024-09-14T18:38:03+00:00 https://www.pacificbridgemedical.com/news-brief/more-new-drugs-being-approved-in-china-than-before/ 2024-09-14T18:36:48+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-new-drug-regulations-improve-access/ 2024-09-14T18:35:02+00:00 https://www.pacificbridgemedical.com/news-brief/europe-too-unhappy-with-chinas-device-procurement-practices/ 2024-09-14T18:33:57+00:00 https://www.pacificbridgemedical.com/news-brief/korean-plans-to-expedite-drug-reimbursement/ 2024-09-14T18:11:32+00:00 https://www.pacificbridgemedical.com/news-brief/vietnams-moh-released-draft-medical-data-management-decree/ 2024-09-14T16:06:06+00:00 https://www.pacificbridgemedical.com/news-brief/china-initiates-a-new-program-for-rare-diseases/ 2024-09-14T15:45:41+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-will-make-more-efforts-to-combat-its-drug-lag-problem/ 2024-09-14T15:44:11+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-new-guidelines-for-local-device-clinical-studies/ 2024-09-14T15:43:26+00:00 https://www.pacificbridgemedical.com/news-brief/koreas-mfds-promotes-the-use-of-ai-medical-devices/ 2024-09-14T15:32:32+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-pilot-program-eases-new-indication-approvals-for-drugs/ 2024-09-12T17:41:07+00:00 https://www.pacificbridgemedical.com/news-brief/india-cracks-down-on-drug-gmp/ 2024-09-12T17:40:40+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asian-regulatory-updates-3/ 2024-09-12T17:40:26+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-start-a-new-program-to-reduce-the-ind-review-time/ 2024-09-12T17:40:12+00:00 https://www.pacificbridgemedical.com/news-brief/the-philippines-starts-a-trial-program-for-device-registration/ 2024-09-12T17:39:25+00:00 https://www.pacificbridgemedical.com/news-brief/singapores-hsa-outlines-a-new-guidance-program-for-change-submission-of-samd-products/ 2024-09-12T17:33:03+00:00 https://www.pacificbridgemedical.com/news-brief/growth-in-the-asian-medical-device-market/ 2024-08-05T21:31:53+00:00 https://www.pacificbridgemedical.com/news-brief/india-medical-device-and-investment-policy-reforms/ 2024-08-05T21:31:07+00:00 https://www.pacificbridgemedical.com/news-brief/china-considers-easing-medical-device-testing-requirement/ 2024-08-05T21:11:11+00:00 https://www.pacificbridgemedical.com/news-brief/important-preparations-for-2010-chinese-pharmacopoeia-implementation/ 2024-08-05T21:05:54+00:00 https://www.pacificbridgemedical.com/news-brief/increasing-awareness-of-rare-diseases-and-orphan-drugs-in-china/ 2024-08-05T21:05:24+00:00 https://www.pacificbridgemedical.com/news-brief/increasing-regulations-on-drugs-in-hong-kong/ 2024-08-05T21:04:58+00:00 https://www.pacificbridgemedical.com/news-brief/japan-updates-program-medical-device-database/ 2024-08-05T21:03:33+00:00 https://www.pacificbridgemedical.com/news-brief/major-hike-in-japan-drug-review-fees-take-effect-april-1/ 2024-08-05T21:00:58+00:00 https://www.pacificbridgemedical.com/news-brief/significant-changes-expected-to-china-government-drug-reimbursements/ 2024-08-05T20:54:36+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-amends-law-on-registration-of-new-drugs/ 2024-08-05T20:51:58+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asian-regulatory-updates-2/ 2024-08-05T18:36:13+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asian-regulatory-updates/ 2024-08-05T17:58:06+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-health-science-authority-publishes-new-guideline-for-approval-of-next-generation-medical-devices/ 2024-08-05T15:40:46+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-promulgates-comprehensive-regenerative-medicine-regulations/ 2024-07-09T15:19:41+00:00 https://www.pacificbridgemedical.com/news-brief/china-cracks-down-on-monopolies-in-pharmaceutical-sector/ 2024-06-14T17:37:24+00:00 https://www.pacificbridgemedical.com/news-brief/aging-japan-now-changing-in-fertility-coverage/ 2024-06-14T17:28:27+00:00 https://www.pacificbridgemedical.com/news-brief/china-updated-medical-device-manufacturing-regulations/ 2024-06-14T15:10:17+00:00 https://www.pacificbridgemedical.com/news-brief/digital-healthcare-continues-to-grow-in-asia/ 2024-06-12T23:52:04+00:00 https://www.pacificbridgemedical.com/news-brief/real-world-evidence-rwe-becoming-more-popular-in-japan/ 2024-06-12T20:12:49+00:00 https://www.pacificbridgemedical.com/news-brief/korea-to-shorten-approval-times-of-innovative-medical-devices/ 2024-06-12T19:55:15+00:00 https://www.pacificbridgemedical.com/news-brief/more-drug-clinical-trials-occurring-in-asia-these-days/ 2024-06-12T19:51:49+00:00 https://www.pacificbridgemedical.com/news-brief/japan-continues-to-expedite-a-priority-agenda-for-samd-products/ 2024-06-12T19:04:00+00:00 https://www.pacificbridgemedical.com/news-brief/korea-introduces-a-new-accelerated-drug-approval-system/ 2024-06-12T19:03:01+00:00 https://www.pacificbridgemedical.com/news-brief/china-will-now-begin-offering-electronic-drug-registration-certificates/ 2024-06-12T19:02:40+00:00 https://www.pacificbridgemedical.com/news-brief/japan-updates-labeling-requirements-for-regenerative-medical-products/ 2024-06-12T19:01:38+00:00 https://www.pacificbridgemedical.com/news-brief/india-plans-comprehensive-drug-database/ 2024-06-12T18:44:24+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-updates-change-notification-guidance-document/ 2024-06-12T18:43:33+00:00 https://www.pacificbridgemedical.com/news-brief/drugs-for-rare-diseases-will-continue-to-thrive-in-china/ 2024-06-12T18:42:36+00:00 https://www.pacificbridgemedical.com/news-brief/japans-pmda-further-examines-ai-applications/ 2024-06-12T18:23:50+00:00 https://www.pacificbridgemedical.com/news-brief/china-lowers-import-tariffs-on-device-imports/ 2024-06-06T20:38:39+00:00 https://www.pacificbridgemedical.com/news-brief/india-government-now-requires-qr-codes-for-apis/ 2024-06-06T20:38:26+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-extends-drug-licenses/ 2024-06-06T20:37:51+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-issues-draft-comments-on-third-batch-of-udis/ 2024-06-06T20:36:04+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-updated-regulations-on-udi/ 2024-06-06T20:11:10+00:00 https://www.pacificbridgemedical.com/news-brief/drug-registration-in-korea-still-slow/ 2024-06-06T19:41:58+00:00 https://www.pacificbridgemedical.com/news-brief/asia-cdx-market-taking-off/ 2024-06-06T19:40:05+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-patent-linkage-system-picking-up-steam/ 2024-06-06T19:39:30+00:00 https://www.pacificbridgemedical.com/news-brief/nmpa-shortens-time-for-supplemental-submissions/ 2024-06-06T19:38:48+00:00 https://www.pacificbridgemedical.com/news-brief/japan-discusses-more-support-for-orphan-drugs/ 2024-06-06T19:38:23+00:00 https://www.pacificbridgemedical.com/news-brief/telemedicine-growing-in-asia/ 2024-06-06T19:27:30+00:00 https://www.pacificbridgemedical.com/news-brief/china-has-new-medical-electric-standards-for-medical-devices/ 2024-06-06T19:15:10+00:00 https://www.pacificbridgemedical.com/news-brief/more-phase-i-drug-studies-being-done-in-asia-than-the-us-and-eu/ 2024-06-06T19:13:44+00:00 https://www.pacificbridgemedical.com/news-brief/digital-health-growing-in-japan/ 2024-06-06T18:54:38+00:00